Bizarre Patents
Pizza Pie With Concentric Rings of Crust
A pizza mold for forming a plurality of concentric raised ridges of dough (i.e., crust) on the surface of a pizza pie.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 5340588 | Liposphere carriers of vaccines Solid, water-insoluble lipospheres including a solid hydrophobic core, having a layer of a phospholipid embedded on the surface of the core, that contain an antigen are disclosed for use in immunizing an animal. The antigen (or "immunogen"), alone or in c... | 08/23/1994 |
| 5317079 | Fatty acid terminated polyanhydride Fatty acid terminated polyanhydrides suitable for use as controlled release matrices in biodegradable sustained release drug delivery systems and methods for making thereof are described. The polymers are more soluble in organic solvents, and have a lower... | 05/31/1994 |
| 5270419 | Polyanhydrides of oligomerized unsaturated aliphatic acids A polyanhydride suitable for use as a matrix material in controlled delivery devices polymerized from monomers of the general formula: ##STR1## wherein R, R', and R" are the same or a different aliphatic chain of C1 to C20 or hy... | 12/14/1993 |
| 5240963 | Branched polyanhydrides Branched polyanhydrides that have superior properties for use in the controlled delivery of substances, prepared by the polymerization of a dicarboxylic acid monomer and a branching agent. The branching agent is a polycarboxylic acid monomer such as 1,3,5... | 08/31/1993 |
| 5227165 | Liposphere delivery systems for local anesthetics A local anesthetic microsuspension system is disclosed that includes lipospheres, that are solid, water-insoluble microparticles that have a layer of a phospholipid embedded on their surface. The core of the liposphere is a solid anesthetic such as lidoca... | 07/13/1993 |
| 5221535 | Sustained release formulations of insect repellent A microsuspension system containing insect repellent is disclosed that includes lipospheres, that are solid, water-insoluble microparticles that have a layer of a phospholipid embedded on their surface. The core of the liposphere is a solid insect repelle... | 06/22/1993 |
| 5189046 | Protein kinase C modulators PKC modulating compounds of the formula ##STR1## Also disclosed are pharmaceutical compositions including these compounds which inhibit PKC activity, methods of using these compounds to inhibit PKC activity in mammals, and intermediates useful in pre... | 02/23/1993 |
| 5188837 | Lipsopheres for controlled delivery of substances A microsuspension system and method for its preparation is disclosed. The microsuspension contain lipospheres, which are solid, water-insoluble microparticles that have a layer of a phospholipid embedded on their surface. The core of the liposphere is a s... | 02/23/1993 |
| 5179189 | Fatty acid terminated polyanhydrides Fatty acid terminated polyanhydrides suitable for use as controlled release matrices in biodegradable sustained release drug delivery systems and methods for making thereof are described. The polymers are more soluble in organic solvents, and have a lower... | 01/12/1993 |
| 5175235 | Branched polyanhydrides Branched polyanhydrides that have superior properties for use in the controlled delivery of substances, prepared by the polymerization of a dicarboxylic acid monomer and a branching agent. The branching agent is a polycarboxylic acid monomer such as 1,3,5... | 12/29/1992 |
| 5171812 | Polyanhydrides of oligomerized unsaturated aliphatic acids A polyanhydride suitable for use as a matrix material in controlled delivery devices polymerized from monomers of the general formula: ##STR1## wherein R, R', and R" are the same or a different aliphatic chain of C1 to C20 or hy... | 12/15/1992 |
| 5135917 | Interleukin receptor expression inhibiting antisense oligonucleotides Disclosed are oligonucleotide compounds that inhibit interleukin receptor expression when administered to a human subject. Also disclosed are pharmaceutical compositions and methods for inhibiting human interleukin receptor expression.... | 08/04/1992 |
| 5122367 | Polyanhydride bioerodible controlled release implants for administration of stabilized growth hormone A controlled release device for the administration of biologically active growth hormone proteins or peptide fragments, and method of preparation thereof, wherein biologically active growth hormone is stabilized and release rate modulated by incorporation... | 06/16/1992 |
| 5079260 | Method for treating inflammation and compounds and compositions suitable for use therein The present invention relates to a method of treating an inflammatory condition, and to compounds and composition suitable for use in such a method, which compounds have the Formula: ##STR1## wherein: X is methylene, ethylene, ethyleneoxy, or oxygen;... | 01/07/1992 |
| 5063245 | Corticotropin-releasing factor antagonism compounds The present invention relates to a method of producing corticotropin-releasing factor (CRF) antagonist activity and thus provides a method of treating a wide range of stress-related disorders, including affective illnesses, such as depression and anxiety,... | 11/05/1991 |
| 5049555 | Antagonists of specific excitatory amino acid receptors as neuroprotectants and anxiolytics The invention pertains to a method and pharmaceutical compositions for treating, preventing or reducing neurodegeneration associated with chronic central nervous system or hypoxic, ischemic and hypoglycemic injury to the central nervous system and for the... | 09/17/1991 |
| 4999417 | Biodegradable polymer compositions Biodegradable polyanhydrides or polyester compositions based on amino acids. The compositions may be used as carriers for drugs or the like or as the drug source itself. The polymers are prepared from amino acids which are modified to include an additiona... | 03/12/1991 |
| 4997904 | Aromatic polyanhydride compositions Aromatic anhydride copolymers containing at least two aromatic diacid units, which are soluble in chloroform or dichloromethane to concentrations between approximately 0.5 to 50% weight/volume, melt at temperatures below 180° C., and have low crystallini... | 03/05/1991 |
| 4906638 | Dextromethorphan potentiator for anticonvulsant composition and method A pharmaceutical composition comprises an anti-epileptic drug that does not inhibit, enhance or otherwise modify dextromethorphan binding to the central nervous system dextromethorphan receptor and an effective amount of dextromethorphan to potentiate the... | 03/06/1990 |
| 4889860 | Oximes of oxymorphone, naltrexone and naloxone as potent, selective opioid receptor agonists and antagonists A potent, selective opioid receptor agonist or antagonist exhibiting properties useful for a longacting analgesic or opiate abuse treatment agent or appetite suppressant having the general formula: ##STR1## wherein R is methyl, cyclopropylmethyl or a... | 12/26/1989 |
| 4761405 | Antagonists of specific excitatory amino acid neurotransmitter receptors having increased potency The invention pertains to novel, potent anticonvulsants, analgesics, cognition enhancers and neuroprotectants achieving their action through the antagonism of specific excitatory amino acid neurotransmitter receptors. In particular, the invention is direc... | 08/02/1988 |
| 4760069 | Oximes of oxymorphone, naltrexone and naloxone as potent, selective opioid receptor agonists and antagonists A potent, selective opioid receptor agonist or antagonist exhibiting properties useful for a long-acting analgesic or opiate abuse treatment agent or appetite suppressant having the general formula: ##STR1## wherein R is methyl, cyclopropylmethyl or ... | 07/26/1988 |
| 4657899 | Antagonists of specific excitatory amino acid neurotransmitter receptors The invention pertains to novel, potent anticonvulsants, analgesics and cognition enhancers achieving their action through the antagonism of specific excitatory amino acid neurotransmitter receptors. In particular, the invention is directed to ω-[2-... | 04/14/1987 |
